Xconomy’s Digital Events →
Joined Great Hill Partners in 2013. (Image: Apperian and Chuck Goldman)
Sponsored · Webinar
Phenotypic Screening & Profiling to Understand a Compound's Disease Impact
Sponsored · Whitepaper
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders